Aurigene Pharmaceutical Services Integrated Drug Discovery (IDD) team comprises of medicinal chemists, computational chemist, biologists, pharmacologists, and toxicologists with extensive experience in delivering developmental candidates for clients. The key component of Aurigene’s IDD programs is a focused and dedicated team of experts, express delivery, shorter timelines with limited budget strives to deliver clients expectations. Our IDD platform spans across discovery and development of large and small molecules with the most effective and efficient means to conduct target validation, translational interrogation, therapeutic discovery, and preclinical development for our clients
Our range of service
Mix and Match programs
We also provide mix and match services which includes the following service combinations
Who is on your team?
In addition to the multidisciplinary group of scientists consisting of chemists, biologists, pharmacologists, and toxicologists, are assigned to your project. We offer an array of help in terms of project management and logistics, integrated drug discovery programs need expert project management who bring personalized attention and efficient management of resource and keeping a track of multitude of activities in parallel and determine the critical paths. Our seasoned project management and senior scientific advisory services team adds value with insight and guidance for a smooth path to a development candidate.
Why Aurigene Pharmaceutical Services?
When you choose Aurigene as your partner, your program benefits from a knowledge-based approach to advancing compounds from hit identification through lead optimization and into development. At Aurigene, we realize that solving the toughest scientific challenges starts with asking the right questions. Our teams work closely with our collaborators in asking those right questions at appropriate time of the project progress cycle and rapidly advance programs towards the target product profile. We also have the capabilities to simultaneously apply multiple modalities for target validation and therapeutic discovery, as per specific target or pathway. With seamless integration into development stages also available, Aurigene IDD offers a hassle-free outsourcing experience that is outcome driven and quality focused
Various customer models:
FTE models with big
pharma as well as rapid hit
8+ IND candidates
Our average candidate
nomination time is 24-28 months
to apply multiple modalities
into development stages
modalities like oncology,
anti-infectives, CNS & inflammation
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.